{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:20:12Z","timestamp":1791127212673,"version":"4.1.0"},"reference-count":49,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,10]]},"abstract":"<jats:p content-type=\"fine-print\"><jats:italic>Object.<\/jats:italic> The most frequent genetic abnormality in human malignant gliomas is loss of heterozygosity (LOH) on chromosome 10. Candidate genes on chromosome 10 that are associated with the prognosis of patients with anaplastic astrocytoma (AA) and glioblastoma (GBM) were evaluated.<\/jats:p>\n<jats:p content-type=\"fine-print\"><jats:italic>Methods.<\/jats:italic> The authors used 12 fluorescent microsatellite markers on both arms of chromosome 10 to study LOH in 108 primary astrocytic tumors. The LOH on chromosome 10 was observed in 11 (32%) of 34 AAs and 34 (56%) of 61 GBMs. No LOH was detected in 13 low-grade gliomas. Loss of heterozygosity was not detected in any AA in the seven patients younger than 35 years, but it was discovered in 41% of the patients older than 35 years. The prognostic significance of LOH at each locus was evaluated in 89 patients older than 15 years; 33 (37%) had supratentorial AAs and 56 (63%) had supratentorial GBMs. The Cox proportional hazards model, adjusted for patient age at surgery, the preoperative Karnofsky Performance Scale score, and the extent of surgical resection revealed that LOH on marker D10S209 near the <jats:italic>FGFR2<\/jats:italic> and <jats:italic>DMBT1<\/jats:italic> genes was significantly associated with shorter survival in patients with AA. The LOH on markers D10S215 and D10S541, which contain the <jats:italic>PTEN\/MMAC1<\/jats:italic> gene between them, was significantly associated with shorter survival in patients with GBM.<\/jats:p>\n<jats:p content-type=\"fine-print\"><jats:italic>Conclusions.<\/jats:italic> In the present study it is found that LOH on chromosome 10 is an age-dependent event for patients with AAs and that LOH on marker D10S209 near the <jats:italic>FGFR2<\/jats:italic> and <jats:italic>DMBT1<\/jats:italic> loci is a significantly unfavorable prognostic factor. It is also reported that LOH on the <jats:italic>PTEN\/MMAC1<\/jats:italic> gene is a significantly unfavorable prognostic factor in patients with GBM.<\/jats:p>","DOI":"10.3171\/jns.2001.95.4.0651","type":"journal-article","created":{"date-parts":[[2009,5,13]],"date-time":"2009-05-13T17:34:32Z","timestamp":1242236072000},"page":"651-659","source":"Crossref","is-referenced-by-count":48,"title":["Analysis of loss of heterozygosity for chromosome 10 in patients with malignant astrocytic tumors: correlation with patient age and survival"],"prefix":"10.3171","volume":"95","author":[{"given":"Kenji","family":"Tada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Kamiryo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ichi","family":"Kuratsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Kochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Saya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukitaka","family":"Ushio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1","series-title":"Am J Hum Genet","first-page":"1260","article-title":"Deletion mapping of gliomas suggest the presence of two small regions for candidate tumor-suppressor genes in a 17-cM interval on chromosome 10q.","volume":"58","author":"Albarosa","year":"1996"},{"key":"b2","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1227\/00006123-198708000-00012","article-title":"Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas.","volume":"21","author":"Ammirati","year":"1987"},{"key":"b3","series-title":"Br J Cancer","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/sj.bjc.6693403","article-title":"Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas.","volume":"81","author":"Balesaria","year":"1999"},{"key":"b4","series-title":"Cancer Genet Cytogenet","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0165-4608(90)90024-5","article-title":"Cytogenetics of human brain tumors.","volume":"47","author":"Bigner","year":"1990"},{"key":"b5","series-title":"Cancer Res","first-page":"405","article-title":"Specific chromosomal abnormalities in malignant human gliomas.","volume":"48","author":"Bigner","year":"1988"},{"key":"b6","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1038\/sj.onc.1202481","article-title":"A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors.","volume":"17","author":"Chernova","year":"1998"},{"key":"b7","series-title":"FASEB J","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1096\/fasebj.7.10.8344489","article-title":"Gene and chromosomal alterations associated with the development of human gliomas.","volume":"7","author":"Collins","year":"1993"},{"key":"b8","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/BF00172709","article-title":"Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials.","volume":"12","author":"Curran","year":"1992"},{"key":"b9","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3171\/jns.1993.78.5.0767","article-title":"Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome.","volume":"78","author":"Devaux","year":"1993"},{"key":"b10","series-title":"Am J Pathol","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0002-9440(10)65135-8","article-title":"Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.","volume":"155","author":"Fujisawa","year":"1999"},{"key":"b11","series-title":"Cancer Res","first-page":"674","article-title":"p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.","volume":"52","author":"Fults","year":"1992"},{"key":"b12","series-title":"Gene Chromosome Cancer","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/gcc.2870070311","article-title":"Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme.","volume":"7","author":"Fults","year":"1993"},{"key":"b13","series-title":"Cancer Res","first-page":"5784","article-title":"Allelotype of human malignant astrocytoma.","volume":"50","author":"Fults","year":"1990"},{"key":"b14","series-title":"Cancer Surv","first-page":"233","article-title":"Genetics and malignant progression of human brain tumours.","volume":"25","author":"Furnari","year":"1995"},{"key":"b15","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/1097-0142(19940801)74:3<920::AID-CNCR2820740320>3.0.CO;2-4","article-title":"Prognostic factors in gliomas. A multivariate analysis of clinical, pathologic, flow cytometric, cytogenetic, and molecular markers.","volume":"74","author":"Ganju","year":"1994"},{"key":"b16","series-title":"Cancer Treat Rep","first-page":"121","article-title":"Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma.","volume":"67","author":"Green","year":"1983"},{"key":"b17","series-title":"Nat Genet","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/ng0694supp-246","article-title":"The 1993\u201394 G\u00e9n\u00e9thon human genetic linkage map.","volume":"7","author":"Gyapay","year":"1994"},{"key":"b18","series-title":"Cancer Res","first-page":"5546","article-title":"Clonal genomic alterations in glioma malignancy stages.","volume":"48","author":"James","year":"1988"},{"key":"b19","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/BF01052902","article-title":"Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach.","volume":"21","author":"Jeremic","year":"1994"},{"key":"b20","series-title":"Hum Genet","first-page":"169","article-title":"Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10.","volume":"92","author":"Karlbom","year":"1993"},{"key":"b21","series-title":"Histological Typing of Tumors of the Central Nervous System","author":"Kleihues","year":"1993"},{"key":"b22","series-title":"Toxicol Pathol","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1177\/019262330002800121","article-title":"Phenotype vs genotype in the evolution of astrocytic brain tumors.","volume":"28","author":"Kleihues","year":"2000"},{"key":"b23","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/sj.onc.1201488","article-title":"Structural and functional evidence for the presence of tumor suppressor genes on the short arm of chromosome 10 in human gliomas.","volume":"16","author":"Kon","year":"1998"},{"key":"b24","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3171\/jns.1994.81.3.0427","article-title":"Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.","volume":"81","author":"Lang","year":"1994"},{"key":"b25","series-title":"Br J Cancer","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/bjc.1994.373","article-title":"Allele loss on chromosomes 10 and 17p and epidermal growth factor receptor gene amplification in human malignant astrocytoma related to prognosis.","volume":"70","author":"Leenstra","year":"1994"},{"key":"b26","series-title":"Int J Cancer","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/(SICI)1097-0215(19980417)79:2<159::AID-IJC11>3.0.CO;2-5","article-title":"Genetic sub-types of human malignant astrocytoma correlate with survival.","volume":"79","author":"Leenstra","year":"1998"},{"key":"b27","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3171\/jns.1985.63.2.0218","article-title":"Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.","volume":"63","author":"Levin","year":"1985"},{"key":"b28","series-title":"Science","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","article-title":"PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.","volume":"275","author":"Li","year":"1997"},{"key":"b29","series-title":"Clin Cancer Res","first-page":"2447","article-title":"Allelic deletion analyses of MMAC\/PTEN and DMBT1 loci in gliomas: relationship to prognostic significance.","volume":"4","author":"Lin","year":"1998"},{"key":"b30","series-title":"Brain Pathol","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/j.1750-3639.1997.tb01062.x","article-title":"A molecular genetic model of astrocytoma histopathology.","volume":"7","author":"Louis","year":"1997"},{"key":"b31","series-title":"Trends Genet","first-page":"412","article-title":"A tiger behind many doors: multiple genetic pathways to malignant glioma.","volume":"10","author":"Louis","year":"1995"},{"key":"b32","series-title":"Int J Oncol","first-page":"983","article-title":"Homozygous deletion of the p16\/MTS-1\/CDKN2 gene in malignant gliomas is infrequent among Japanese patients.","volume":"5","author":"Mochizuki","year":"1999"},{"key":"b33","series-title":"Nat Genet","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/ng0997-32","article-title":"DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3\u201326.1 is deleted in malignant brain tumours.","volume":"17","author":"Mollenhauer","year":"1997"},{"key":"b34","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/sj.onc.1201618","article-title":"Identification of a human homolog of the Drosophila neuralized gene within the 10q25.1 malignant astrocytoma deletion region.","volume":"16","author":"Nakamura","year":"1998"},{"key":"b35","series-title":"Gene Chromosome Cancer","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/gcc.2870050111","article-title":"Loss of heterozygosity for 10q loci in human gliomas.","volume":"5","author":"Rasheed","year":"1992"},{"key":"b36","series-title":"Oncogene","first-page":"2243","article-title":"Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25.","volume":"10","author":"Rasheed","year":"1995"},{"key":"b37","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1227\/00006123-198204000-00007","article-title":"Effect of age and reoperation on survival in the combined modality treatment of malignant astrocytoma.","volume":"10","author":"Salcman","year":"1982"},{"key":"b38","series-title":"Cancer Res","first-page":"1820","article-title":"Differential expression of MMAC\/PTEN in glioblastoma multiforme: relationship to localization and prognosis.","volume":"59","author":"Sano","year":"1999"},{"key":"b39","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3171\/jns.1992.76.5.0772","article-title":"A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma.","volume":"76","author":"Shapiro","year":"1992"},{"key":"b40","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/jns.1989.71.1.0001","article-title":"Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.","volume":"71","author":"Shapiro","year":"1989"},{"key":"b41","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0360-3016(93)90203-8","article-title":"Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials.","volume":"26","author":"Simpson","year":"1993"},{"key":"b42","series-title":"Jpn J Cancer Res","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1349-7006.1996.tb00231.x","article-title":"Deletion mapping of chromosome 10 in human glioma.","volume":"87","author":"Sonoda","year":"1996"},{"key":"b43","series-title":"Gene Chromosome Cancer","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/gcc.2870120404","article-title":"Two tumor suppressive loci on chromosome 10 involved in human glioblastomas.","volume":"12","author":"Steck","year":"1995"},{"key":"b44","series-title":"Nat Genet","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/ng0497-356","article-title":"Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.","volume":"15","author":"Steck","year":"1997"},{"key":"b45","series-title":"Br J Cancer","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/bjc.1991.168","article-title":"Multiple sequential molecular abnormalities in the evolution of human gliomas.","volume":"63","author":"Venter","year":"1991"},{"key":"b46","series-title":"Brain Pathol","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1750-3639.1993.tb00721.x","article-title":"Subsets of glioblastoma multiforme defined by molecular genetic analysis.","volume":"3","author":"von Deimling","year":"1993"},{"key":"b47","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1056\/NEJM198012043032303","article-title":"Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.","volume":"303","author":"Walker","year":"1980"},{"key":"b48","series-title":"Brain Pathol","first-page":"217","article-title":"Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.","volume":"3","author":"Watanabe","year":"1996"},{"key":"b49","series-title":"Proc Natl Acad Sci USA","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1073\/pnas.91.2.484","article-title":"Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas.","volume":"91","author":"Yamaguchi","year":"1994"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/95\/4\/article-p651.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/95\/4\/article-p651.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/95\/4\/article-p651.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T21:15:25Z","timestamp":1679865325000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/95\/4\/article-p651.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":49,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3171\/jns.2001.95.4.0651","relation":{},"ISSN":["0022-3085"],"issn-type":[{"value":"0022-3085","type":"print"}],"subject":[],"published":{"date-parts":[[2001,10]]}}}